Ultrasound assessment of endothelial function: A technical guideline of the flow-mediated dilation test

Paula Rodriguez-Miguelez, Nichole Seigler, Ryan A. Harris

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cardiovascular disease is the primary cause of mortality and a major cause of disability worldwide. The dysfunction of the vascular endothelium is a pathological condition characterized mainly by a disruption in the balance between vasodilator and vasoconstrictor substances and is proposed to play an important role in the development of atherosclerotic cardiovascular disease. Therefore, a precise evaluation of endothelial function in humans represents an important tool that could help better understand the etiology of multiple cardio-centric pathologies. Over the past twenty-five years, many methodological approaches have been developed to provide an assessment of endothelial function in humans. Introduced in 1989, the FMD test incorporates a forearm occlusion and subsequent reactive hyperemia that promotes nitric oxide production and vasodilation of the brachial artery. The FMD test is now the most widely utilized, non-invasive, ultrasonic assessment of endothelial function in humans and has been associated with future cardiovascular events. Although the FMD test could have clinical utility, it is a physiological assessment that has inherited several confounding factors that need to be considered. This article describes a standardized protocol for determining FMD including the recommended methodology to help minimize the physiological and technical issues and improve the precision and reproducibility of the assessment.

Original languageEnglish (US)
Article numbere54011
JournalJournal of Visualized Experiments
Volume2016
Issue number110
DOIs
StatePublished - Apr 1 2016

Fingerprint

Dilatation
Ultrasonics
Guidelines
Cardiovascular Diseases
Brachial Artery
Nitric oxide
Hyperemia
Vascular Endothelium
Vasoconstrictor Agents
Pathology
Vasodilator Agents
Forearm
Vasodilation
Nitric Oxide
Mortality
FND protocol

Keywords

  • Brachial artery
  • Cardiovascular disease
  • Endothelial function
  • Endothelium
  • Flow-mediated dilation
  • Issue 110
  • Medicine
  • Ultrasound

ASJC Scopus subject areas

  • Neuroscience(all)
  • Chemical Engineering(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ultrasound assessment of endothelial function : A technical guideline of the flow-mediated dilation test. / Rodriguez-Miguelez, Paula; Seigler, Nichole; Harris, Ryan A.

In: Journal of Visualized Experiments, Vol. 2016, No. 110, e54011, 01.04.2016.

Research output: Contribution to journalArticle

@article{7fda42df1a594ee88a09ecb367af70e3,
title = "Ultrasound assessment of endothelial function: A technical guideline of the flow-mediated dilation test",
abstract = "Cardiovascular disease is the primary cause of mortality and a major cause of disability worldwide. The dysfunction of the vascular endothelium is a pathological condition characterized mainly by a disruption in the balance between vasodilator and vasoconstrictor substances and is proposed to play an important role in the development of atherosclerotic cardiovascular disease. Therefore, a precise evaluation of endothelial function in humans represents an important tool that could help better understand the etiology of multiple cardio-centric pathologies. Over the past twenty-five years, many methodological approaches have been developed to provide an assessment of endothelial function in humans. Introduced in 1989, the FMD test incorporates a forearm occlusion and subsequent reactive hyperemia that promotes nitric oxide production and vasodilation of the brachial artery. The FMD test is now the most widely utilized, non-invasive, ultrasonic assessment of endothelial function in humans and has been associated with future cardiovascular events. Although the FMD test could have clinical utility, it is a physiological assessment that has inherited several confounding factors that need to be considered. This article describes a standardized protocol for determining FMD including the recommended methodology to help minimize the physiological and technical issues and improve the precision and reproducibility of the assessment.",
keywords = "Brachial artery, Cardiovascular disease, Endothelial function, Endothelium, Flow-mediated dilation, Issue 110, Medicine, Ultrasound",
author = "Paula Rodriguez-Miguelez and Nichole Seigler and Harris, {Ryan A.}",
year = "2016",
month = "4",
day = "1",
doi = "10.3791/54011",
language = "English (US)",
volume = "2016",
journal = "Journal of visualized experiments : JoVE",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "110",

}

TY - JOUR

T1 - Ultrasound assessment of endothelial function

T2 - A technical guideline of the flow-mediated dilation test

AU - Rodriguez-Miguelez, Paula

AU - Seigler, Nichole

AU - Harris, Ryan A.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Cardiovascular disease is the primary cause of mortality and a major cause of disability worldwide. The dysfunction of the vascular endothelium is a pathological condition characterized mainly by a disruption in the balance between vasodilator and vasoconstrictor substances and is proposed to play an important role in the development of atherosclerotic cardiovascular disease. Therefore, a precise evaluation of endothelial function in humans represents an important tool that could help better understand the etiology of multiple cardio-centric pathologies. Over the past twenty-five years, many methodological approaches have been developed to provide an assessment of endothelial function in humans. Introduced in 1989, the FMD test incorporates a forearm occlusion and subsequent reactive hyperemia that promotes nitric oxide production and vasodilation of the brachial artery. The FMD test is now the most widely utilized, non-invasive, ultrasonic assessment of endothelial function in humans and has been associated with future cardiovascular events. Although the FMD test could have clinical utility, it is a physiological assessment that has inherited several confounding factors that need to be considered. This article describes a standardized protocol for determining FMD including the recommended methodology to help minimize the physiological and technical issues and improve the precision and reproducibility of the assessment.

AB - Cardiovascular disease is the primary cause of mortality and a major cause of disability worldwide. The dysfunction of the vascular endothelium is a pathological condition characterized mainly by a disruption in the balance between vasodilator and vasoconstrictor substances and is proposed to play an important role in the development of atherosclerotic cardiovascular disease. Therefore, a precise evaluation of endothelial function in humans represents an important tool that could help better understand the etiology of multiple cardio-centric pathologies. Over the past twenty-five years, many methodological approaches have been developed to provide an assessment of endothelial function in humans. Introduced in 1989, the FMD test incorporates a forearm occlusion and subsequent reactive hyperemia that promotes nitric oxide production and vasodilation of the brachial artery. The FMD test is now the most widely utilized, non-invasive, ultrasonic assessment of endothelial function in humans and has been associated with future cardiovascular events. Although the FMD test could have clinical utility, it is a physiological assessment that has inherited several confounding factors that need to be considered. This article describes a standardized protocol for determining FMD including the recommended methodology to help minimize the physiological and technical issues and improve the precision and reproducibility of the assessment.

KW - Brachial artery

KW - Cardiovascular disease

KW - Endothelial function

KW - Endothelium

KW - Flow-mediated dilation

KW - Issue 110

KW - Medicine

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84964814340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964814340&partnerID=8YFLogxK

U2 - 10.3791/54011

DO - 10.3791/54011

M3 - Article

C2 - 27167596

AN - SCOPUS:84964814340

VL - 2016

JO - Journal of visualized experiments : JoVE

JF - Journal of visualized experiments : JoVE

SN - 1940-087X

IS - 110

M1 - e54011

ER -